Article
BRCA1 and BRCA2 mutations and breast cancer.
Discovery medicine - 1 Nov 2011
Narod Steven A, Salmena Leonardo
Abstract excerpt
Genetic testing for BRCA mutations is expanding in clinical oncology centers worldwide. Testing may help target unaffected high-risk women for prevention and/or close surveillance and may also help affected women choose the best chemotherapy. Annual screening with MRI appears to be an effective surveillance strategy and should be added to mammographic screening. It is important to have an understanding of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
